Wolfson Group Champions the Multi-Category Wellness Consumer
September 29, 2026 — Wolfson Group spotlights the multi-category wellness consumer, spanning weight, cognition, gut health, and aging. See how its brands adapt to holistic wellness.
Curated Health Wellness News
NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
Anne Therese Aesthetic Medicine Offers Non-Surgical Skin and Body Treatments in Cape Coral
September 29, 2026 — Anne Therese Aesthetic Medicine offers IPL/BBL Photofacial and CoolSculpting Elite in Cape Coral. Personalized plans for sun damage and fat reduction. Book a consultation.
Neurosurgeon Avery Buchholz Named 2026 Castle Connolly Top Doctor
September 29, 2026 — Avery L. Buchholz, MD, FAANS, named 2026 Castle Connolly Top Doctor for third year. Board-certified neurosurgeon at Capital Spine and Pain Institute.
Laser Center of Marin Urges Early Fall Booking for Holiday Injectables
September 29, 2026 — Laser Center of Marin advises booking injectable and laser treatments early this fall for optimal holiday results. Physician-supervised care in Corte Madera, CA.
Helix BioPharma Strengthens Board with Four New Directors
September 28, 2026 — Helix BioPharma appoints four new directors to its Board, strengthening governance and expertise in biotech, finance, and clinical development. Learn more.
Viromed Advances Cold Plasma Products, Confirms 2026 Guidance
September 28, 2026 — Viromed Medical AG reports H1 2026 progress: cold plasma pipeline, ViroCAP® med approval, revenue up to €2.5M, and confirms full-year guidance.
Novogenia AG Reports H1 2026 Results, Advances Personalized Health Growth
September 28, 2026 — Novogenia AG H1 2026 report: revenue EUR 25.7M, DNA analysis growth, cost cuts, strategic partnerships, and global expansion in personalized health.
Redcare Pharmacy Raises 2026 Guidance on Strong Rx Momentum
September 28, 2026 — Redcare Pharmacy raises FY2026 revenue guidance again, driven by strong Rx momentum in Germany. Rx revenue now expected at EUR 730-760M, total growth 16-18%.
Nanox Tackles Global Imaging Gap with Integrated 3D Diagnostics Platform
September 28, 2026 — Nanox integrates FDA-cleared 3D tomosynthesis to expand imaging access. With $4.2M Q2 revenue, it targets global disparities in radiology.
Regentis Biomaterials Leads Shift to Structural Knee Cartilage Repair
September 28, 2026 — Regentis Biomaterials advances GelrinC, a cell-free hydrogel implant for knee cartilage repair, shifting from symptom management to structural intervention. CE Mark approved, U.S. trial enrollment targeted for 2026.
Regentis Biomaterials Leads Shift to Structural Knee Cartilage Repair
September 28, 2026 — Regentis Biomaterials' GelrinC hydrogel implant shows 100% greater KOOS improvement than microfracture, targeting early knee cartilage repair. CE Marked in Europe, U.S. trials underway.
BioMedWire Highlights Glioblastoma Research and CNS Pharmaceuticals
September 28, 2026 — BioMedWire highlights glioblastoma research and CNS Pharmaceuticals' drug development efforts. Learn about the fight against this deadly brain cancer and the latest breakthroughs.
Stacey Eisenberg Named Finalist for 2026 Austin Business Woman Award
September 28, 2026 — Stacey Eisenberg of A Place At Home - North Austin is a finalist for the 2026 Austin Business Woman Health Expert award. Learn about her impact in home care.
NanoViricides Begins Phase II Trial of NV-387 for Ebola in DRC
September 28, 2026 — NanoViricides starts Phase II trial of NV-387 oral gummies for Ebola in DRC. The trial aims to establish dosing and evaluate effectiveness against Bundibugyo Ebolavirus.
ECGI Holdings to Acquire Avanta Group in $400M Revenue Milestone Deal
September 28, 2026 — ECGI Holdings signs LOI to acquire Avanta Group for up to 15.6M preferred shares, aiming to build a diversified healthcare platform with Medicare Advantage plan and health tech.
TransCode's TTX-MC138 Shows 71% Disease Control in Phase 1a
September 28, 2026 — TransCode Therapeutics reports updated Phase 1a data for TTX-MC138, showing 71% disease control and no dose-limiting toxicities in advanced solid tumors.
Avatar Medical and Kyber Secure €3.7M to Expand Immersive 3D Imaging
September 28, 2026 — Avatar Medical and Kyber secure €3.7M France 2030 grant to develop Avatar MediVerse, expanding immersive 3D medical imaging across the surgical care pathway.
CCHR Demands Toxicology Testing for Psychiatric Drugs in Violent Crimes
September 28, 2026 — CCHR urges mandatory toxicology screening for psychiatric drugs in violent crimes after a Las Vegas murder-suicide case reveals multiple drugs. Learn why this evidence gap matters.
MIMS Group Accelerates Global Growth with AI-Enabled Clinical Platforms
September 28, 2026 — MIMS Group accelerates global growth with AI-enabled clinical platforms, expanding MIMS Pulse and eMIMS Plus to new markets and transforming medical communications.
Cami Aesthetics: Start Morpheus8 Now for Holiday Skin
September 27, 2026 — Cami Aesthetics advises starting Morpheus8 RF microneedling by early fall to achieve firmer skin before the holidays. Learn about the 3-session series, downtime, and results.